Flutiform 125 mg/5 microgram per metered dose pressurised inhalation, suspension
*Company:
Mundipharma Pharmaceuticals Limited - Formerly Napp LaboratoriesStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 07 March 2025
File name
IE-PIL-Flutiform-clean.pdf
Reasons for updating
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
This medicine contains fluorinated greenhouse gases.
Each inhaler contains 11.2 grams of fluorinated greenhouse gas HFA227 corresponding to 0.036 tonne CO2 equivalent (global warming potential GWP = 3220).
Updated on 30 March 2023
File name
flutiform 125mcg-5mcg-spc-clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
IE MAH Address Change
Updated on 30 March 2023
File name
flutiform 50-5-125-5-250-10mcg-pil-clean.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
IE MAH Address Change
Mundipharma Pharmaceuticals Limited - Formerly Napp Laboratories
Address:
United Drug House Magna Drive, Magna Business Park, Citywest Road, Dublin 24, IrelandMedical Information E-mail:
medicalinformation@mundipharma.ieTelephone:
Medical Information Direct Line:
+44 174 882 8867